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Abstract
NKp30, a natural cytotoxicity receptor expressed on NK cells is critically involved in direct cytotoxicity against various tumor
cells and directs both maturation and selective killing of dendritic cells. Recently the intracellular protein BAT3, which is
involved in DNA damage induced apoptosis, was identified as a ligand for NKp30. However, the mechanisms underlying the
exposure of the intracellular ligand BAT3 to surface NKp30 and its role in NK-DC cross talk remained elusive. Electron
microscopy and flow cytometry demonstrate that exosomes released from 293T cells and iDCs express BAT3 on the surface
and are recognized by NKp30-Ig. Overexpression and depletion of BAT3 in 293T cells directly correlates with the exosomal
expression level and the activation of NK cell-mediated cytokine release. Furthermore, the NKp30-mediated NK/DC cross
talk resulting either in iDC killing or maturation was BAT3-dependent. Taken together this puts forward a new model for the
activation of NK cells through intracellular signals that are released via exosomes from accessory cells. The manipulation of
the exosomal regulation may offer a novel strategy to induce tumor immunity or inhibit autoimmune diseases caused by NK
cell-activation.
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Introduction
Natural killer (NK) cells are lymphocytes involved in innate and
adaptive immunity. Unlike T and B lymphocytes, NK cells do not
possess antigen specific receptors. NK cell recognition of target cells
and communication with different immune modulatory cells are
regulated by a set of integrated signals provided by corresponding
inhibitory and activating receptors [1,2]. The well known killer-
inhibitory receptors (KIRs) recognize the MHC-class molecules on
self-cells and protect them against cytotoxicity. Virus-infected and
tumor transformed cells down-regulate the MHC molecules and
instead express inducible ligands for the activating receptor,
NKG2D and the natural cytotoxicity receptors (NCRs) [3]. The
knowledge on the ligands for NCRs is still limited. It has been
shown that NKp30 and NKp46 recognize heparan-sulphate
structures on tumor or virus-infected target cells [4–6]. We and
others identified proteins residing within the target cells as potential
NCR ligands including the intermediate filament-protein vimentin
as an NKp46-binding protein [7] and the nuclear factor BAT3 as
an NKp30-interacting partner [8]. However, it is still unclear how
these intracellular proteins become exposed to the cell surface to
activate NK cells. The contribution of such intracellular factors to
the NK/DC cross talk is also not yet analyzed. This is of special
interest for NKp30 and its tumor associated ligand BAT3, since
NKp30 (NCR3, CD337) plays a crucial role in target-cell lysis as
well as in the cross talk between NK cells and iDCs [9,10].
Intracellular BAT3 has been reported to regulate apoptosis in a
variety of settings [11–13]. Recently, p53 and apoptosis-inducing
factor have been identified as BAT3 targets after DNA damage[14]
and ER stress [15] respectively. Since extracellular BAT3 acts as a
ligand for a natural killer cell receptor [8], it might constitute a
molecular link from damaged cells to the immune system.
BAT3 contains a so-called BAG-domain (Bcl-2-associated
athanogene domain found in the BAG family of proteins) that
interacts with Hsp70 [12]. Reminiscent to BAT3, extra-cellular
Hsp70 stimulates NK cell function and it is also involved in the
activation of professional antigen-presenting cells such as macro-
phages and dendritic cells. Recently it was shown that intracellular
Hsp70 is released via exosomes from tumor cells [16]. Exosomes
are membrane micro-vesicles (diameter of 50–100 nm) [17] with
the ability to direct the communication among cells in the immune
system. Electron microscopy studies suggest that exosomes
originate from the endocytic pathway called multi-vesicular bodies
(MVBs) [23]. It is known that iDC-derived exosomes directly
activate T cells in tumor immunity [18]. Moreover, pulsing of
dendritic cells with immunogenic tumor-derived exosomes leads to
T lymphocyte activation [19,20].
Here we investigate the role of BAT3 for the NK-DC cross talk
and the mechanisms that render the intracellular protein BAT3
accessible to the NKp30 cell-surface receptor.
Results and Discussion
BAT3 is a multifunctional protein that is released from tumor
cells in response to cellular stress engaging NKp30 on NK cells [8].
Intracellular BAT3 is involved in apoptosis [13] and also in the
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3377p53-mediated gene transcription in response to DNA damage [14].
So far, nothing is known about theexpression and function of BAT3
in dendritic cells.Sinceprevious studies indicate that NKp30 plays a
crucial role in triggering NK cell-mediated cytotoxicity and induces
maturation of iDCs by engaging undefined ligands [9,10], we
initially analyzed the expression pattern of BAT3 in iDCs. BAT3
was detectable in lysates of monocyte-derived iDCs, and released
into the extracellular compartment in response to non-lethal heat
shock (Fig. 1A). Moreover, a BAT3- specific ELISA demonstrated
that extracellular BAT3 derived from iDCS was specifically
recognized by NKp30-Ig, whereas no binding to NKp46-Ig was
observed (Fig. 1B). These data show that iDCs secrete BAT3, that
specifically binds to NKp30 and support previous reports suggesting
a role for NKp30 but not for NKp46 in the NK-DC cross-talk [9].
Laser Scanner Microscopy revealed that intracellular BAT3 was
predominantly detectable in the cell nuclei and also on the cell
membrane of heat shocked iDCs (Fig. 1C, merge). Interestingly, co-
localization with surface MHC class I molecules (HLA-A, B, and C)
was observed (Fig. 1C). Taken together, the expression profile of
BAT3 in iDCs is in line with a potential NKp30 ligand.
The putative BAT3 promoter is glycine and cysteine rich and
possesses heat shock elements at position -125 [21] and within the
first intron of the ubiquitin-like domain of BAT3. Therefore we
investigated whether BAT3 expression was regulated on the
transcriptional level. Real-time PCR revealed an increase of BAT3
mRNA in response to a non-lethal heat shock in tumor cells and
iDCs (Fig. 1D). The enhanced mRNA expression in dendritic cells
was reproducible, although the induction varied from donor to
donor. A consistent correlation of the BAT3 protein release
estimated in a BAT3-specific sandwich ELISA (Fig. 1E) and the
mRNA increase was demonstrated.
We next analyzed the functional role of the NKp30-ligand
BAT3 for iDC killing and maturation. A europium release assay
with activated NK cells as effector cells and monocyte- derived
iDCs as target cells was performed in the presence or absence of
BAT3-masking antibodies. Addition of anti-BAT3 (rabbit poly-
clonal, [8]) inhibited NK cell mediated cytotoxicity significantly
when compared to a rabbit control serum ((p=0.019); Fig. 2A).
Moreover, down regulation of BAT3 protein upon nucleofec-
tion of BAT3 siRNA into iDCs resulted in a decrease of
cytotoxicity compared to the control siRNA (Fig. 2B).
The maturation of DCs leads to high expression of MHC class-I
molecules and thus protects from NK-mediated cytotoxicity. It is
well known that mature DCs (mDCs) are less susceptible to lysis as
compared to iDCs [9]. However, subsequent blocking of MHC-
class-I molecules on mature DCs with HLA-A, B, C specific mAb
lead to efficient lysis by NK cells and this effect could be blocked
by adding BAT3 antibodies (Fig. 2C).
The NKp30-dependent NK-DC cross talk also results in iDC
maturation (12). Thus, we explored the role of soluble protein on
the maturation of iDCs in NK-DC-co-culture experiments and
analyzed the expression of the co-stimulatory molecule CD86. As
expected co-cultivation of monocyte-derived iDCs with NK cells
induced enhanced expression of CD86 (Fig. 2D). In this setting the
up-regulation of CD86 was reduced in the presence of soluble
recombinant BAT3 (Fig. 2D) indicating that BAT3 has a
substantial impact on the NK cell-mediated iDC-maturation.
The effect of recombinant BAT3 on NK cell cytotoxicity has
not been addressed so far. Therefore we performed europium
release assays using NK cells either pre-stimulated with soluble or
with immobilized recombinant BAT3. We observed that NK-
dependent lysis of Raji cells was inhibited when NK cells were
stimulated with purified soluble HisBAT3 (Fig. 2E). Similar
inhibition was achieved upon blocking the NKp30 receptor with
a masking monoclonal antibody. The control protein (HisBB4) did
not alter NK cell cytotoxicity. A similar reduction in NKp30-
mediated cytotoxicity was also reported for the viral ligand pp65
[22]. On the other hand, we observed that immobilized BAT3 had
an opposite effect enhancing the cytotoxicity of NK cells against
the target cells compared to the control protein HisBB4 (Fig. 2F).
This data confirm previous results indicating that recombinant
BAT3 in a soluble form inhibits cytokine secretion of NK cells,
whereas immobilized BAT3 activates TNF-a and IFN-c release
[8]. Taken together, it was demonstrated that the NKp30-
mediated DC-killing and DC maturation is at least partly
dependent on BAT3.
To assess the underlying mechanisms of BAT3 on NK cell
function as an inhibitor in soluble form and an activator when
immobilized, we directly tested whether BAT3 is secreted in a
complex structure such as exosomes. Exosomes are membrane
microvesicles (diameter of 50–100 nm) [17] that direct the
Figure 1. Expression of BAT3 on immature dendritic cells. (A)
Western blot to detect BAT3 in total lysates and supernatant of heat
shock treated monocyte-derived iDCs. (B). ELISA plates were coated
with recombinant proteins, buffer control (Neg), NKp46-Ig and NKp30-
Ig (concentration of 100 ng/ml), followed by incubation with 100 mlo f
concentrated supernatant obtained from heat shock treated iDCs and
detected with anti-BAT3. Data represents absorbance at 492 nm. (C)
Laser Scanning Microscopy to visualize HLA- A, B, C and BAT3 on
dendritic cells upon staining with specific primary antibodies and
labelled secondary antibodies. HLA-A, B, and C (green), BAT3 (red) and
merge (right-yellow). Blue represents Hoechst33342 staining of cell
nuclei. (D) Quantitative Real time PCR to detect BAT3 mRNA in 293T
and iDCs upon exposure to heat shock. The Y-axis determines the fold
change; where the untreated samples were normalized to factor 1. (E)
Supernatant was collected from iDCs cells either untreated or treated
with non-lethal heat shock (Heat shock) and analysed in specific BAT3
ELISA (sandwich method) to determine the amount of BAT3 in the
supernatant. Error bars represent the standard deviation of duplicate
samples. One representative experiment of three is shown.
doi:10.1371/journal.pone.0003377.g001
BAT3-Exosomes and NK Cells
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secrete exosomes similar to immune regulatory cells such as
antigen-presenting cells (APC), T cells, reticulocytes and platelets.
Exosomes were purified by ultracentrifugation from supernatant
of 293T cells and their presence was confirmed by electron
microscopy (Fig. 3A). As expected, the exosomes appeared as
clusters of vesicles each surrounded by a double layer membrane.
A specific immunostaining for BAT3 was detectable indicating
that the exosomes expressed BAT3 (Fig 3A, right panel). This was
confirmed by Western blot analysis of exosomes secreted from
tumor cells and from iDCs (Fig. 3B). Moreover, sucrose gradient
analysis was performed proving that BAT3 was associated with
membrane vesicles (data not shown). The analysis of several
control proteins revealed a differential expression for Hsp70,
Lamp2 and CD9 between exosomes derived from tumor cells
versus iDC-derived exosomes (Fig. 3B).
Until today little is known on the expression pattern of NCR
ligands. Their cellular distribution has been detected only on a
limited number of tumor cells [24,25]. A comprehensive analysis
showed NKp30L expression on normal and neoplastic cells by
staining with NKp30-Ig fusion constructs [26]. More specifically,
NKp30-Ig staining was observed in intra-cellular vesicular
compartments very similar to early endosomal marker [26] which
corresponds to the formation of exosomes. This supports our
observation that the cellular ligand BAT3 is localized in
endosomal vesicles and secreted in exosomal form. However,
our data cannot rule out the existence of different isoforms of
BAT3 that are released in exosomal or in soluble form. For
instance, the release of soluble inhibitory forms could be mediated
through shedding activity, as described for the ligands engaging
the NKG2D receptor [27]. The inhibitory role of soluble
recombinant BAT3 observed in our experiments might be due
Figure 2. Role of BAT3 for iDCs and the effect of purified BAT3 on NK cell function. (A) Standard Europium release assay: Inhibition of NK-
dependent lysis of iDCs in the presence of anti-BAT3 was significant (paired t-test, p-value=0.008). (B) iDCs transfected with either control siRNA or
BAT3 siRNA were co-incubated with NK cells for 4 hours at 37uC. The decrease of iDC lysis upon BAT3 down regulation was significant (p=0.01). (C)
Lysis of mature DCs upon pre-incubation with control antibodies, anti-HLA-ABC and/or anti-BAT3. (D) Co-culture of iDCs with activated NK cells at 5:1
ratio (iDC:NK) promotes the maturation of iDCs as shown by FACS analysis to detect expression of the maturation marker CD86. Inhibition of this
effect is achieved by soluble purified BAT3. The y-axis represents the mean fluorescence intensity (MFI). (E) The lysis of Raji cells is inhibited by soluble
BAT3 and anti-NKp30 compared to the control protein His BB4. The decrease of the lysis was significant (paired t-test, p value=0.019). (F) NK cells
were pre-stimulated with immobilized HisBB4 (control) and purified BAT3 prior a cytotoxicity assay with Raji cells as targets at different effector :
target cell ratios. NK cells were derived from different donors for each experiment. Error bars for the lysis experiments represent standard deviation of
three replicates. One representative experiment of four is shown.
doi:10.1371/journal.pone.0003377.g002
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PLoS ONE | www.plosone.org 3 October 2008 | Volume 3 | Issue 10 | e3377Figure 3. Bio-chemical characterization of the released BAT3. (A) Detection of BAT3 expression on exosomes by electron microscopy {left
panel: gold antibody control (1400006) and right panel: exosomes stained with anti-BAT3 antibody (1400006)}. (B) Western blotting to detect BAT3,
Hsp70, Lamp-2 and CD9 in exosomal fractions (30 mg) and lysate (10 mg) of 293T cells and iDCs. (C,D) FACS analysis to detect BAT3 and various
BAT3-Exosomes and NK Cells
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signalling.
To assess directly the expression of BAT3 on the surface of
exosomes, we used flow cytometric analysis. Purified exosomes
from iDCs (Fig. 3C) and 293T cells (Fig. 3D) were incubated with
latex beads of 4 mm in diameter and stained with antibodies
directed against BAT3 [11] and several exosomal proteins. The
expression of BAT3 and CD-9 (a tetra spin) was clearly detectable
on the surface of both exosomal fractions. iDC-derived exosomes
expressed also CD86, HLA class-I and HLA-DR as previously
described. Positive staining for Hsp70 and Lamp-2 on 293T-
derived exosomes revealed the purity of exosomes (Fig. 3D).
Ligands for the NKG2D receptor were not detectable using
NKG2D-Ig staining (not shown), suggesting that NKG2D
engagement is independent of exosomes derived from 293T cells.
We then used BAT3-overexpressing 293T cells to directly prove
the binding of NKp30 to BAT3 on the exosomal surface. As
determined by flow-cytometry, exosomes derived from BAT3-
transfected 293T cells express high levels of BAT3 on their surface
(Fig. 3E). Purified exosomes were stained with Ig fusion proteins
(human-Ig, CD30-Ig, NKp46-Ig and NKp30-Ig). The binding of
NKp30-Ig to BAT3 on exosomes was specific and not observed for
human-Ig and CD30-Ig (Fig. 3E). These experiments suggest that
exosomal BAT3 acts as a membrane associated molecule which is
presented to NKp30. Interestingly, recognition of so far unknown
ligands for NKp46 was detectable using NKp46-Ig. A coordinated
expression of ligands for different NCRs on exosomes may explain
the cross-stimulation of NCRs in response to selective activation
[2,28]. Staining of iDC-derived exosomes with human Ig
constructs was not feasible since Fc-receptors are present on
exosomes derived from human dendritic cells.
Next we analyzed whether extracellular BAT3 was detectable in
a physical association with Hsp70. The interaction of BAT3 and
Hsp70 was so far only analyzed with respect to the intracellular
regulation of apoptosis [12], although it is known that Hsp70 is
involved in the regulation of immune cells in its extracellular,
exosomal form [16,29]. Extracellular BAT3 was precipitated from
tumor-cell-derived supernatant upon a non-lethal heat shock using
antibodies either binding BAT3 or Hsp70 suggesting that there is a
BAT3/Hsp70 complex (Fig. 3F). Thus, the association of BAT3
and Hsp70 suggests that both factors are associated with exosomes
and may act in combination to activate NK cells. It is known that
heat shock does not influence the exosomal secretory rate, but it
significantly enhances the Hsp70 content of exosomes isolated
from cell supernatant [30]. Since the exosomal BAT3-expression is
also induced in response to heat shock, both factors might act as
intracellular danger sensors in a coordinative manner.
We subsequently investigated the biological role of BAT3
surface-positive exosomes for NK cell activation. Exosomes with
different BAT3 expressions levels were obtained from wildtype
293T cells (wt), upon BAT3-overexpression (BAT3) or siRNA-
mediated down regulation (si-B) (Fig. 4A). NK cells were
stimulated with these exosomes and the supernatant was collected
for TNF-a and IFN-c ELISA. Wild-type exosomes clearly
stimulated the release of the inflammatory cytokines, and as
expected, the cytokine release was even increased in response to
BAT3- overexpressing exosomes (Fig. 4B). Interestingly, NK cells
treated with BAT3-depleted exosomes failed to produce TNF-a
and IFN-c, whereas a robust release was observed with control
exosomes (si-c) derived from control si-RNA transfected cells.
Analogous results were obtained with iDC-derived exosomes
(Fig. 4C). Exosomes were purified from untreated iDCs or from
heat shock treated iDCs to increase the expression level of BAT3
in the supernatant. The release of TNF-a and IFN-c was in fact
stronger in response to heat shock treated exosomes and observed
in both allogenic and autologous settings. Thus, the biological
activity of exosomes correlated directly with the BAT3 expression
level indicating that BAT3 is crucial for the exosomal-dependent
activation of NK cells.
The data demonstrate a novel role for exosomes released from
accessory cells that initiate the innate function of NK cells and may
shape the adaptive immune response in a BAT3-dependent
manner. It was shown that BAT3 acts as a dendritic cell-
associated ligand providing an explanation how and when BAT3 -
a intracellular protein - is secreted and engages the NKp30
receptor on effector cells. This is based on the following findings: (i)
iDCs and tumor cells release BAT3 surface-positive exosomes; (ii)
exosomes release was induced by moderate heat shock and
correlated with an increase of BAT3 mRNA level; (iii) iDC-
derived BAT3 positive exosomes induce cytokine secretion and (iv)
BAT3 is critically involved in NK cell-dependent maturation and
killing of iDCs. The association of extracellular BAT3 with
exosomes suggests that BAT3 activates NK cells in combination
with ‘‘co-factors’’ engaging receptors distinct from NKp30. This is
further supported by the observation that BAT3-mediated NK cell
activation cannot be completely blocked using masking NKp30
antibodies [8]. It is also known that several triggering NK
receptors are activated in a coordinative manner [28]. Confirming
this model it was shown recently that Hsp70 surface-positive
exosomes and inducible NKG2D ligands expressed on tumor cells
synergistically promote the activation of mouse NK cells resulting
in a reduced in vivo tumor growth and progression [31].
One pathway that induces the expression of NKG2D ligands is
the p53-mediated DNA damage response [32,33]. It is known that
BAT3 is crucial for the post-translational modification of p53
allowing the transcriptional up-regulation of p53-target genes such
as p21 and puma [14]. The cellular DNA damage-response results
also in the enhanced secretion of exosomes mediated via TSAP6
(tumor suppressor-activated pathway 6) that is a direct p53
transcriptional target gene [34,35]. Further experiments will
elucidate whether BAT3 is the key component linking the nuclear
DNA damage response to the immune system via the release of
immune-stimulatory exosomes.
The exosomal release of danger signals that alert NK cells may
be considered as a priming signal and is in favour with a two-step
activation model of human NK cells involving a priming and a
triggering event. The NK cell activation via extracellular factors
may thus result in yet unappreciated bystander effects exerted by
NK cells. Recently, it was also demonstrated that resting NK cells
acquire general functionality through trans-presentation of IL-15
by DCs [36]. A ‘‘priming’’ event has also been described for NK
cells in tumor cell recognition, since the NK cell-mediated killing
surface markers on exosomes, that were purified from iDCs (C) or 293T cells (D) that were immobilized to latex beads. Grey background represents
isotype control. (E) FACS analysis of exosomes derived from control transfected (wt) or BAT3-transfected (BAT3) 293T cells revealed over-expression
of BAT3 on the exosomal surface. Specific binding of anti-BAT3, NKp30-Ig and NKp46-Ig was detectable. Grey histograms: background (secondary
antibody) staining of beads coated with exosomes. (F) Western blot analysis demonstrates that the enhanced secretion of BAT3 into the supernatant
obtained from tumor cells (293T) when treated with heat shock (HS, lane: 3) or left untreated (UT, lane: 2). Lanes 4 and 5 demonstrate the co-
immunoprecipitation of BAT3 by using either a polyclonal BAT3 antibody (4
th lane) or a monoclonal Ab against Hsp70 (5
th lane). The western blot is
stained for BAT3. Lane 1 (M) indicates the marker.
doi:10.1371/journal.pone.0003377.g003
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extracellular factors derived from unrelated tumor cells that were
sensitive for NK cell lysis [37].
Direct in vivo evidence for the interaction of BAT3/NKp30 for
the recognition and elimination of tumor cells remains difficult
since NKp30 is a pseudogene in mouse strains [38]. However
aberrant expression of BAT3 is observed in certain human tumors
such as malignant melanoma [39] and its identification as a
putative tumor suppressor gene in colon carcinoma [40] clearly
suggest a role in tumor biology.
Materials and Methods
Cells, cell transfection, proteins and antibodies
293T cells, a human fibroblast kidney cell line, were used for the
purification of exosomes. Human NK cells were separated from
peripheral blood mononuclear cells (PBMCs) using the NK Cell
Isolation Kit and VarioMACS (Miltenyi, Bergisch Gladbach,
Germany).
Separated polyclonal NK cells were cultivated in RPMI medium
supplemented with 50 mg/mL penicillin, 50 mg/mL streptomycin,
10% fetal calfserum and 10 U/mL recombinant human IL-2 (R&D
Systems, Wiesbaden, Germany) at 37uCw i t h5 %C O 2. Primary
immature dendritic cells (iDCs) were differentiated from adherent
peripheral blood monocytes in the presence of IL-4 and GM-CSF
(Immunotools, Germany) at the final concentration of 20 ng/ml and
50 ng/ml, respectively for 5 days. For maturation of the DCs we
have used TNF-a at a concentration of 50 ng/ml for 2 days. The
purity of NK cells (CD32,C D 5 6 +,N K p 4 6 + and NKp30+)a n d
DCs (CD142,C D 1 a +,C D 8 0 + and CD86+)w a se v a l u a t e db yf l o w -
cytometric analysis. All the conjugated antibodies are from BD
biosciences except NKp30 and NKp46 (Beckman Coulter).
The sequence encoding the extracellular domain of NKp30 was
amplified by PCR from NKL-derived cDNA and cloned into the
expression vector pCDNA3.1 (Invitrogen, Karlsruhe, Germany),
which contained the human IgG1 kappa leader sequence (N-
terminal) and the genomic DNA of the Fc portion of human IgG1
(C-terminal). The CD30 extracellular sequence was inserted in
frame between the IgG1 kappa leader and the genomic DNA of
the Fc portion of human IgG1. The control human IgG1 was
obtained from pFuse2 vector. Human-Ig, NKp30-Ig and CD30-Ig
fusion proteins were purified from the supernatant of transfected
293T cells with protein-G sepharose beads as recommended by
the manufacturer (Amersham Bioscience, Freiburg, Germany).
Recombinant NKp46-Ig was purchased from R&D Systems,
Wiesbaden, Germany.
Figure 4. Exosomal BAT3 regulates NK cell-function. (A) Western Blot to detect BAT3 in exosomal fractions upon over expression and
depletion. Exosomes purified from untransfected cells (WT), BAT3-transfected cells (BAT3), control siRNA- transfected cells (si-c) and BAT3 siRNA-
transfected cells were analysed by Western blotting to detect BAT3. (B) Exosomes were purified from media (PBS), untransfected 293T cells (wt),
BAT3-transfected 293T cells (BAT3), control si-RNA (si-c) and BAT3 si-RNA (si-B) transfected 293T cells and used to stimulate NK cells. NK cell-
supernatant was collected and used for a cytokine ELISA (TNF-a and IFN-c). (C) NK cells were stimulated with exosomes derived from untreated iDCs
(iDC-NHS exosomes) or upon heat shock (iDC-HS exosomes) for cytokine ELISA (left panels). NK cell-mediated cytokine release was estimated upon
stimulation with exosomes derived from allogenic and autologous iDCs (right panels). Primary immune cells were derived from different donors for
each experiment. The means of duplicates and the concentration (pg/ml) are indicated. One representative experiment of three is shown.
doi:10.1371/journal.pone.0003377.g004
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expression vectors pCDNA3.1-His (Invitrogen, Karlsruhe, Ger-
many) in frame with a C-terminal 6xhistidine tag (His)6. BAT3-
transfected 293T cells were exposed to a non-lethal heat shock at
42uC for 30 minutes followed by a recovery period at 37uC for two
hours. The supernatant was collected and purified using NiNTA
affinity chromatography according to Qiagen, Hilden, Germany
(The QIAexpressionist, 2003) dialysed against PBS.
We used the following primary antibodies: Anti-NKp30
(mAb1849, R&D Systems, Wiesbaden, Germany) for FACS and
blocking experiments; BH1-2A as anti-NKp30 isotype control
(kindly provided by Lemke, Kiel), anti-Hsp70 (WB-analysis-
SPA810, Biomol, Hamburg, Germany), anti-LAMP2b (WB-
analysis-ab18529, Abcam, Germany), anti-Hsp70 (FACS analysis-
cmHsp70.1-kindly provided by G. Multhoff, Mu ¨nchen) and
chicken polyclonal anti-BAT3 (ab37751, Abcam, Germany). The
generation of the BAT3-specific rabbit antiserum (raised against
the COOH-terminal region as an antigen ((NH2)-RKVKP-
QPPLSDAYLSGMPAK was described elsewhere[11]. The sec-
ondary antibodies were obtained from Dianova GmbH, Ham-
burg, Germany.
Immunoprecipitation. 293T cells were transfected with an
expression construct encoding histidine-tagged BAT3 using
lipofectamine (Invitrogen, Karlsruhe, Germany). 48 hours post
transfection the cells were treated with a non-lethal heat shock at
42uC for 30 minutes and recovered for 1–2 hrs at 37uC. The heat
shock supernatant was collected and incubated with rabbit
polyclonal sera against BAT3 and Hsp70 monoclonal antibodies
(SPA810, Biomol, Hamburg, Germany) for one hour and followed
by incubation with protein-A beads over night. The beads were
washed and subjected to immunoblotting for detection of BAT3.
Isolation and Purification of Exosomes. Exosomes were
purified as described elsewhere (Thery et al., 1999). In brief 293T
cells were exposed to a non-lethal heat shock at 42uC for
30 minutes followed by a recovery period at 37uC for two hours
(BAT3-SN). Exosomes were purified from the supernatant by
three successive centrifugations at 3006 g (5 min), 12006 g
(20 min) and 10 0006 g (30 min) to eliminate cells and debris,
followed by centrifugation for 1 h at 100 0006g. The exosomal
pellet was washed once in a large volume of PBS, centrifuged at
100 0006g for 1 h and re-suspended in PBS.
Electron Microscopy. PBS washed exosomal pellets were
resuspended and fixed in 4% paraformaldehyde in PBS at 20uC
for 15 minutes. Coated nickel grid was placed on top of a
suspension drop followed by post-fixation with OsO4. The grids
were immunolabeled with BAT3 specific antibodies followed by
staining with 5 nm gold particles. Preparations were analyzed with
a Zeiss EM-109 electron microscope (Carl Zeiss, Oberkochen,
Germany).
ELISA binding assay of iDC supernatant to fusion
proteins. Monocyte-derived immature dendritic cells were
treated with heat shock for 30 minutes at 42uC and recovered at
37uC for another 30 minutes. The supernatant was collected and
concentrated with viva-spin column (100 kDa cut-off) ensuring the
concentration of higher-molecular weight structures. Different
human-Ig fusion proteins (100 ng/well) were coated on plates in
duplicates and were incubated with iDC supernatant derived from
heat shock treated cells (the supernatant contains exosomes), for
2 hours at room temperature and detected using rabbit polyclonal
BAT3 specific antibody and the corresponding anti-rabbit
secondary antibody.
Coupling of exosomes and FACS Analysis of exosome-
coated beads. Exosomes(30 mg)wereincubatedwith4.5-micron
microsphere polybead carboxylate latex beads (Polysciences) for
30 minutes at room temperature. The beads were washed once with
PBS and blocked with 2% BSA in PBS for 40 minutes. Beads were
washed again for 2 times with PBS and incubated with various
human Ig fusion proteins and different antibodies as specified, and
analysed on a Becton Dickinson FACS Calibur using Cell Quest Pro
software. Beads alone were gated and isotype-matched antibodies
were used as controls for the fluorescence analysis.
mRNA Analysis. Total cellular RNA was isolated from heat
shock-treated and untreated 293T or immature dendritic cells
using the Qiagen RNeasy Mini Kit according to the
manufacturer’s recommendations. Reverse transcription was
carried out using the QuantiTect Rev. Transcription Kit
(Qiagen). Quantification of the mRNA encoding for BAT3 was
performed using LightCycler technology (Roche Diagnostics).
Quantitative PCR was performed in a total reaction volume of
20 ml using the QuantiTect SYBR Green PCR Kit. The following
primers were used: BAT3-for: CTATTATCCAGCAGGACA-
TTCAGAG; BAT3 rev: GCTAAGGATCATCAGCAAAGG
and for the internal control housekeeping gene c-abl, for: CTT-
CATCCACAGAGATCTTGCTG and c-abl-rev: ATACTCC-
AAATGCCCAGACG. Housekeeping gene and target gene were
quantified simultaneously in duplicates in one LightCycler run,
together with the appropriate non-template controls. The
difference in RNA quality and quantity between samples was
normalized as given by the ratio of the copy number of the target
gene and the copy number of c-abl.
Immunofluorescence. Monocyte-derived immature
dendritic cells were stressed with heat shock and were plated
overnight on poly-lysine coated cover slips. The cells were washed
with PBS and fixed with 4% para-formaldehyde for 15 min at
25uC and also by ice-cold methanol for 10 min at 220uC. After
the cells were washed with PBS, they were blocked with 10%
bovine serum in PBS for 1 h at 25uC and further incubated with
optimally diluted primary antibodies for overnight at 4uC. The
cells were washed and the respective primary antibodies were
detected using fluorescently labelled secondary antibodies, goat
anti-mouse Alexa-flour 488 and goat anti-rabbit Alexa-flour635
(Molecular probes, Invitrogen) diluted in blocking buffer. The
nuclei were stained with Hoechst 33342 (DNA staining). The
cover slips were mounted onto slides with mounting medium (aqua
poly/mount – Polysciences, Inc). The slides were examined with
FLUOVIEW FV1000 laser scanning microscope with an objective
lens UPLSAPO 606 W NA:1.20. The images were processed
using software Image J and Adobe Photoshop.
Transfection of BAT3 siRNA. 1.5610
6 cells (triplicates)
were transfected with control siRNA (Alexa 488 conjugated
siRNA) and a specific siRNA targeting BAT3 (Qiagen) using
quantifect transfection reagent method (Qiagen). AMAXA
nucleofection protocol was used for the transfection into
immature dendritic cells.
Cytotoxicity assays. The cytotoxicity was estimated in a
standard 4 hour europium release assay in a 96-well micro titer
plate in a total volume of 200 ml with 5610
3 target cells and at
different effector: target ratios. When mentioned, NK cells
(effector cells) were incubated with 30% serum for 30 minutes at
4uC, washed and incubated with the monoclonal anti-NKp30
(R&D Systems, mAb1849) in the final concentration of 10 mg/ml
for 1 hour at 4uC to block NKp30. NK cells were stimulated with
immobilized or soluble recombinant BAT3 at a concentration of
1 mg/ml for 24–36 hours and then used as effector cells. The
blocking anti-BAT3 serum (rabbit polyclonal) was used in a 1:1000
dilution. The MHC class I molecules on mature dendritic cells
(preincubated with human serum) were blocked using HLA-A, B,
C antibody (Mouse IgG1k Clone: G46-2.6, BD Biosciences). In all
BAT3-Exosomes and NK Cells
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the maximum release of the target cells.
IFN-c and TNF-a assay. 5610
4 primary NK cells were
incubated for 48 hours with medium or exosomes derived from
293T cells either vector (mock) or BAT3-transfected (BAT3-SN)
and with purified exosomes derived from dendritic cells. The NK
cell-derived supernatant was analyzed (final concentration 1:10
diluted) using IFN-c and TNF-a -ELISA Detection Kits (R&D
Systems, Wiesbaden Germany). The absorbance of the plates was
measured using the ELISA-reader a-Quant (Bio-Tek, Bad
Friedrichshall, Germany). Cyotkine release experiments were
performed from NK cells purified from PBMCs of different
donors. Various batches of NK cells were used for activation in
different settings.
Statistical analysis. The results of the NK cell-activation
assays are indicated as means6standard deviation. Significance
was calculated with the GraphPad Prism software (San Diego, CA)
using student paired t test. For preparation of the figures –
softwares such as Adobe Photoshop, Image J and WinMDI were
used.
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